Pulmonary Failure
6
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
17%
1 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Prospective Evaluation of a RIsk Score for Postoperative Pulmonary COmPlications in Europe
Innovative Technologies for the Treatment of Pulmonary and Heart Failure
Adaptation of Alveolar-capillary Diffusion at Effort of Subjects Suffering From Complex Congenital Heart Disease
Non-respiratory Comorbidities Observed in Pulmonary French Transplant Patients With Cystic Fibrosis
Remote Ischemic Preconditioning in High Risk Cardiovascular Surgery Patients
Human Tissue Distribution of Orally Supplemented Natural Vitamin E Tocotrienol